CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Roopa Industries Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Roopa Industries Ltd
6-2-1012
3rd floor, TGV Mansion, Khairatabad
Phone: +91 8096330007p:+91 8096330007 HYDERABAD, 500004  India Ticker: 530991530991
Business Summary
Roopa Industries Limited is engaged in active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is engaged in the manufacturing of bulk drugs/drug intermediates. The Company’s products include N,N- dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is a product used by the manufacturers of the Cephalosporin group of Antibiotics and Statins. It is used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to Agriculture. Glucosamine is a sheet anchor product that is a nutraceutical / nutritional supplement. Bromine And Its Derivatives offers agrochemicals, dyes, various organic and inorganic for medical & veterinary products, gasoline applications, water purification compounds, disinfectants, insecticides, and pesticides.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
Yes------

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Tumbalam G.Raghavendra 68 10/1/2018 10/1/2015
Chief Financial Officer Bheemaneni V.Vardhan 7/10/2020 7/10/2020
Company Secretary, Compliance Officer Indani VenkataLakshmi 6/1/2022 6/1/2022
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 35 (As of 3/31/2022)
Outstanding Shares: 7,865,520 (As of 9/30/2023)
Stock Exchange: BOM
Fax Number: +91 4023310379


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024